The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

By afschroeder • February 13, 2026

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J. The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? Transl Gastroenterol Hepatol. 2026 Jan 23;11:2. doi: 10.21037/tgh-25-75. PMID: 41675310; PMCID: PMC12887280.

Tags: adjuvant chemotherapy (ACT), Cedars Sinai DoM, circulating tumor DNA (ctDNA), Colon cancer, Hematology/Oncology, minimal residual disease (MRD), Publications

Related Posts

Association of donor heavy alcohol use with graft failure after deceased-donor liver transplantation stratified by donor sex and macrosteatosis in the OPTN/UNOS registry

Han S, Agopian VG, Steggerda JA, Lee J, Kim M, Kim IK, Kwon JH, Sanford A, Lee YT, Yang JD. Association of donor heavy alcohol[...]

Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multi-site Conjoint Analysis

Kao KD, Troost JP, Yang JD, Salgia R, Woolen SA, Mehta N, Hoteit MA, Jalal PK, El Dahan KS, Daher D, Quirk L, Patel N,[...]

Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After Delivery

Shree S, Pike M, Yee LM, Levine L, Simhan H, Silver RM, Greenland P, Saade G, Bairey Merz CN, Chung J, Cleary EM, Grobman W,[...]